Filter by: Subject

Filter by: Subject

Results Per Page:

Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Extensively drug-resistant tuberculosis (XDR-TB) (3)
Public health (3)
Whole genome sequencing (WGS) (3)
Adolescent girls and young women (AGYW) (2)
Africa (2)
Antiretroviral therapy (ART) (2)
Chlamydia trachomatis (2)
Drug-resistant tuberculosis (DR-TB) (2)
Enterobacteriaceae (2)
Epidemics (2)
HIV prevention (2)
Infection (2)
Lymphogranuloma venereum (LGV) (2)
Meningitis (2)
Mobilome (2)
Molecular epidemiology (2)
Multidrug-resistant tuberculosis (MDR-TB) (2)
Mycobacterium tuberculosis (2)
Mycoplasma genitalium infection (2)
Neisseria gonorrhoeae infection (2)
Patients (2)
Phylogenomics (2)
Pre-exposure prophylaxis (PrEP) (2)
Resistome (2)
Rifampicin-resistant tuberculosis (2)
Sub-Saharan Africa (SSA) (2)
Transmission (2)
Treatment (2)
Urinary tract infection (UTI) (2)
Whole-genome sequencing (WGS) (2)
Women (2)
24-loci MIRU-VNTR typing (1)
Acinetobacter baumannii (1)
Acquired drug resistance (1)
Acquired immune deficiency syndrome (AIDS) (1)
Activity space (1)
Adult gonorrhea (1)
Agarose (1)
Age (1)
AmpC (1)
Anaerobic growth (1)
Animals (1)
Antenatal care (ANC) (1)
Antibiotic (1)
Antibiotic sensitivity (1)
Antibiotics (1)
Antifungal susceptibility (1)
Antimicrobial resistance (1)
Antimicrobial susceptibility (1)
Antimicrobial susceptibility testing (AST) (1)
Antintiretroviral therapy (ART) (1)
Anyplex™ plus (1)
Attributable risk (1)
Automation (1)
Azithromycin (AZM) (1)
Bacillus Calmette–Guerin (BCG) (1)
Bacteria (microorganisms) (1)
Bacterial cell wall (1)